Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > I am quietly back in.

<< Previous

Bullboard Posts

Next >>

Post by woundedkneeon Mar 04, 2021 6:48am

262 Views

Post# 32712700

I am quietly back in.

And don't get me wrong..I am not a trader, because I suck at that. I am looking for safety and am now invested heavily in ATE and SVA. With the share price now being what it is, it's almost like buying a house. So if you're in, you're in. One thing I did notice yesterday, just seconds after the close, a huge ask of over 20 thousand shares appeared at 5 dollars. Not sure if or what this may mean, but I've never seen anything like that before..I mean the size of the ask.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China